Hexadecylphosphoserine (TFA)
Hexadecylphosphoserine TFA is a phospholipid molecule that contains a long-chain alkyl (hexadecyl) and a phosphoserine group, giving it a high affinity for the cell membrane. Hexadecylphosphoserine TFA can exert antitumor activity by modulating [Ca++]i and its related signaling pathways, making it useful for research in the field of breast cancer[1].
Product Specifications
UNSPSC
12352211
Target
Calcium Channel
Related Pathways
Membrane Transporter/Ion Channel; Neuronal Signaling
Applications
Cancer-programmed cell death
Field of Research
Cancer
Purity
98.0
Smiles
OC([C@@H](N)COP(OCCCCCCCCCCCCCCCC)(O)=O)=O.OC(C(F)(F)F)=O
Molecular Formula
C21H41F3NO8P
Molecular Weight
523.52
References & Citations
[1]Bergmann J, et al. Multiple effects of antitumor alkyl-lysophospholipid analogs on the cytosolic free Ca2+ concentration in a normal and a breast cancer cell line. Anticancer Res. 1994 Jul-Aug;14 (4A) :1549-56.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, stored under nitrogen)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNCB1619-500 1x 500 µL
CD9 (TSPAN29) (Motility-Related Protein-1) (CD9/1619), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC471491-500 1x 500 µL
PAX8 (Renal Cell Marker) (PAX8/1491), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
TRC-D455420-2.5MG 2.5 mg
2-Diisopropylaminoethyl Ester Xanthene-9-carboxylic Acid Hydrochloride
Sign In for Pricing
View Details 